Legato Capital Management’s CONMED CNMD Stock Holding History

Legato Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Hold	8,210	–	–	0.02%	598
2026 Q1	$290K	Sell	8,210 -6,677	-45%	-$272K	0.03%	646
2025 Q4	$604K	Sell	14,887 -7,058	-32%	-$307K	0.05%	496
2025 Q3	$1.03M	Sell	21,945 -3,271	-13%	-$170K	0.11%	283
2025 Q2	$1.31M	Sell	25,216 -4,386	-15%	-$241K	0.16%	210
2025 Q1	$1.79M	Buy	29,602 +2,202	+8%	+$142K	0.24%	122
2024 Q4	$1.88M	Buy	27,400 +7,997	+41%	+$557K	0.25%	120
2024 Q3	$1.4M	Buy	19,403 +9,530	+97%	+$672K	0.17%	206
2024 Q2	$684K	Buy	+9,873	New	+$720K	0.09%	358
2024 Q1	–	Sell	-3,735	Closed	-$409K	–	574
2023 Q4	$409K	Buy	+3,735	New	+$386K	0.05%	453
2023 Q3	–	Sell	-1,740	Closed	-$236K	–	566
2023 Q2	$236K	Buy	+1,740	New	+$212K	0.03%	505

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Legato Capital Management's CNMD Position: Q2 2026 in Review

Legato Capital Management held its CONMED (CNMD) position steady in Q2 2026 at 8,210 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #598.

Legato Capital Management first reported a position in CNMD in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.88M in Q4 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Legato Capital Management held 8,210 shares of CONMED worth $269K as of Q2 2026.
Legato Capital Management left its CONMED share count unchanged in Q2 2026.
CONMED made up 0.02% of Legato Capital Management's portfolio in Q2 2026, its #598 holding.
Legato Capital Management first reported a position in CONMED in Q2 2023 and has held it in 11 quarters since.
Legato Capital Management's CONMED position peaked at $1.88M in Q4 2024.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.